Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study
- 30 April 1997
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 19 (2), 243-258
- https://doi.org/10.1016/s0149-2918(97)80113-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasiaThe Prostate, 1996
- Primary Care Practitioners: An Analysis of their Perceptions of Voiding Dysfunction and Prostate CancerJournal of Urology, 1996
- Patient Reactions to a Program Designed to Facilitate Patient Participation in Treatment Decisions for Benign Prostatic HyperplasiaMedical Care, 1995
- New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United StatesArchives of Internal Medicine, 1995
- Long-term results of medical therapies for benign prostatic hyperplasiaCurrent Opinion in Urology, 1995
- Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgensJournal of Clinical Endocrinology & Metabolism, 1995
- The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasiaThe Prostate, 1993
- Validation of a new quality of life questionnaire for benign prostatic hyperplasiaJournal of Clinical Epidemiology, 1992
- Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal malesAtherosclerosis, 1988
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987